Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M22,523Revenue $M4,061Net Margin (%)4.7Z-Score3.4
Enterprise Value $M24,803EPS $1.8Operating Margin %12.9F-Score4
P/E(ttm))141Cash Flow Per Share $6.5Pre-tax Margin (%)5.5Higher ROA y-yN
Price/Book2.610-y EBITDA Growth Rate %0Quick Ratio1.9Cash flow > EarningsY
Price/Sales5.15-y EBITDA Growth Rate %16.4Current Ratio2.6Lower Leverage y-yY
Price/Cash Flow15.8y-y EBITDA Growth Rate %-18.5ROA % (ttm)1.6Higher Current Ratio y-yN
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)2.6Less Shares Outstanding y-yN
Payout Ratio %27.0Shares Outstanding M134ROI % (ttm)11.7Gross Margin Increase y-yN

Gurus Latest Trades with PRGO

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRGOJoel Greenblatt 2014-09-30 Buy $139 - $158.85
($149.08)
$ 168.1413%New holding, 1665 sh.1,665
PRGOGeorge Soros 2014-06-30 Sold Out -0.13%$126.87 - $157.2
($141.62)
$ 168.1419%Sold Out0
PRGORay Dalio 2014-06-30 Sold Out -0.08%$126.87 - $157.2
($141.62)
$ 168.1419%Sold Out0
PRGOGeorge Soros 2014-03-31 Buy 0.13%$145.74 - $167.6
($157.73)
$ 168.147%New holding, 85000 sh.85,000
PRGORay Dalio 2014-03-31 Buy 0.08%$145.74 - $167.6
($157.73)
$ 168.147%New holding, 62322 sh.62,322
PRGORon Baron 2014-03-31 Reduce-0.03%$145.74 - $167.6
($157.73)
$ 168.147%Reduce -38.61%77,865
PRGORobert Bruce 2013-12-31 Buy 0.43%$125.11 - $156.88
($144.29)
$ 168.1416%New holding, 9926 sh.9,926
PRGORon Baron 2013-12-31 Reduce-0.04%$125.11 - $156.88
($144.29)
$ 168.1416%Reduce -37.61%126,830
PRGOGeorge Soros 2013-12-31 Sold Out -0.03%$125.11 - $156.88
($144.29)
$ 168.1416%Sold Out0
PRGOGeorge Soros 2013-09-30 Buy 0.03%$116.83 - $134.23
($124.86)
$ 168.1435%New holding, 19000 sh.19,000
PRGORon Baron 2013-09-30 Reduce-0.07%$116.83 - $134.23
($124.86)
$ 168.1435%Reduce -36.19%203,294
PRGOMeridian Funds 2013-06-30 Add0.92%$113.14 - $121.16
($118.55)
$ 168.1442%Add 72.42%482,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRGO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PRGO Joel Greenblatt 2014-09-301,66500New Buy
PRGO Vanguard Health Care Fund 2014-09-303,305,6522.471.3+2.96%
PRGO Ron Baron 2014-09-3079,3070.060.05+1.19%
PRGO Robert Bruce 2014-09-309,9260.010.41
PRGO Mariko Gordon 2014-09-3028,4940.020.19
PRGO Ruane Cunniff 2014-09-301,710,7061.281.4-0.37%
PRGO John Keeley 2014-09-3030,2630.020.09-1.08%
PRGO Ken Fisher 2014-09-30477,5040.360.15-1.79%
PRGO Meridian Funds 2013-06-30482,1000.362.2+72.42%
Premium Most recent portfolio changes are included for Premium Members only!


PRGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
MORRIS HERMAN JRDirector 2014-11-14Sell200$154.428.88view
Yu LouisExecutive VP Global Quality 2014-11-10Sell259$155.118.4view
Kochan SharonEVP, GM International 2014-11-10Sell5,367$156.367.53view
O'Connor DonalDirector 2014-11-04Sell0$07.53view
Brown Judy LExecutive VP & CFO 2014-11-03Sell3,515$160.64.69view
Brown Judy LExecutive VP & CFO 2014-10-01Sell3,515$150.7211.56view
Kochan SharonEVP, GM International 2014-09-03Sell1,116$15012.09view
KINGMA TODD WExecutive VP, General Counsel 2014-09-03Sell2,250$149.6512.36view
Brown Judy LExecutive VP & CFO 2014-09-02Sell3,515$149.3212.6view
Farrington ThomasSenior VP and CIO 2014-09-02Sell1,741$150.3611.82view

Press Releases about PRGO :

    Quarterly/Annual Reports about PRGO:

    News about PRGO:

    Articles On GuruFocus.com
    Fournier Finds Time for His Own Investments in the Third Quarter Dec 17 2014 
    David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
    David Rolfe Comments on Perrigo Jan 27 2014 
    Weekly Insider Sells Highlight: ROC, PRGO, JCI, TEL, DISH Dec 16 2013 
    Weekly CFO Sells Highlight: FleetCor Technologies Inc., Facebook Inc., Perrigo Company, WellPoint In Dec 15 2013 
    Three Companies Gain in Bargain Portfolio Sep 26 2013 
    Meridian Funds Comments on Perrigo Aug 28 2013 
    Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
    The Truth About the Impact of Dividend Reinvesting Apr 10 2013 
    Baron Funds Comments on Perrigo Feb 06 2013 

    More From Other Websites
    Stocks Off Highs But Stay Positive; Nike Drags Dow Dec 19 2014
    Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Senior Notes Dec 02 2014
    Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w Dec 02 2014
    Perrigo Announces FDA Approval And Launch Of The Generic Version Of Pennsaid® 1.5% w/w Dec 02 2014
    Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares Nov 26 2014
    Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares Nov 26 2014
    Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary,... Nov 24 2014
    Perrigo Company plc Announces The Pricing Of Senior Notes Offering By Its Finance Subsidiary,... Nov 24 2014
    Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary,... Nov 24 2014
    Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In... Nov 24 2014
    Perrigo Company plc Announces Underwriters' Full Exercise Of Option To Purchase Ordinary Shares In... Nov 24 2014
    Perrigo Company plc Announces Proposed Public Offering Of Senior Notes Of Its Finance Subsidiary,... Nov 24 2014
    Perrigo Announces The Launch Of A Generic Version Of Astellas' Protopic® Ointment 0.1% And 0.03% Nov 24 2014
    Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed® (Testosterone... Nov 24 2014
    Perrigo Confirms First to File Patent Challenge for Generic Version of Aveed® (Testosterone... Nov 24 2014
    Perrigo Announces The Launch Of A Generic Version Of Astellas' Protopic® Ointment 0.1% And 0.03% Nov 24 2014
    Perrigo Company plc Announces the Pricing of its Offering of Ordinary Shares Nov 20 2014
    Perrigo Company plc Announces the Pricing of its Offering of Ordinary Shares Nov 20 2014
    Perrigo (PRGO) Is Today's Unusual Social Activity Stock Nov 20 2014
    Perrigo to Sell Stock to Fund Omega Deal Nov 20 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK